dc.date.accessioned2020-07-14T00:02:30Z
dc.date.available2020-07-14T00:02:30Z
dc.date.created2020-07-14T00:02:30Z
dc.date.issued2020
dc.identifierhttps://hdl.handle.net/20.500.12866/8319
dc.identifierhttps://doi.org/10.1093/infdis/jiaa127
dc.description.abstractTo investigate the role of serum cytokine assays to distinguish between active from treated syphilis among serofast patients, we recruited individuals into a prospective cohort study. Participants underwent routine syphilis screening. We selected specimens from a majority cohort of serofast participants with treated and active syphilis. We analyzed specimens with a 62-cytokine multiplex bead-based enzyme-linked immunosorbent assay. Cytokines, BDNF and TNFB, were most predictive. We built a decision tree that was 82.4% accurate, 100% (95%CI: 82%-100%) sensitive, and 45% (95%CI, 18%-75%) specific. Our decision tree differentiated between serum specimens of serofast participants with treated syphilis and active syphilis.
dc.languageeng
dc.publisherOxford University Press
dc.relationJournal of Infectious Diseases
dc.relation1537-6613
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectcytokine
dc.subjecttumor necrosis factors
dc.subjectsyphilis
dc.subjectbrain-derived neurotrophic factor
dc.subjectdecision trees
dc.subjectserum specimen
dc.titleThe application of cytokine expression assays to differentiate active from previously treated syphilis.
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución